NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Fortrea Holdings (FTRE): Evaluating Valuation After Raised 2025 Revenue Guidance and Improved Q3 Results

Fortrea Holdings (FTRE) shared its third quarter earnings, showing an uptick in revenue and a narrower net loss compared to last year. The company also raised its full-year 2025 revenue guidance, signaling greater confidence in upcoming performance. See our latest analysis for Fortrea Holdings. After Fortrea Holdings announced improved third-quarter results and a raised revenue outlook, the market responded with a 67.5% share price gain over the past 90 days. Still, its year-to-date share...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

A Look at Liquidia’s (LQDA) Valuation Following Strong YUTREPIA Launch and First Profitable Quarter

Liquidia (LQDA) caught the market’s attention after reporting third-quarter earnings that showed a major revenue jump and its first profitable quarter since launching YUTREPIA, its therapy for pulmonary hypertension. See our latest analysis for Liquidia. After a blockbuster quarter, Liquidia’s share price has soared, boasting a 25% gain in the past three months and a stunning year-to-date return of over 110%. Total shareholder return has been even more impressive, reaching 136% in the past...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

StoneX Group (SNEX): Exploring Current Valuation After Recent Period of Consistent Performance

StoneX Group (SNEX) has seen its stock hold steady recently, with only modest changes over the past week and month. Investors may be considering its longer-term performance and consistent profitability as they evaluate the next move. See our latest analysis for StoneX Group. StoneX Group’s share price is still up nearly 29% for the year to date despite a recent pullback, and the 1-year total shareholder return sits at an impressive 33%. While momentum has cooled after delivering a remarkable...
NYSE:GVA
NYSE:GVAConstruction

Granite Construction (GVA): Exploring Valuation Following Recent Share Price Cooldown

Granite Construction (GVA) has seen its stock ease off by around 6% over the past month, even though revenue has remained steady and the company has reported significant growth in annual net income. The company’s longer-term returns remain in positive territory. See our latest analysis for Granite Construction. After a strong run earlier in the year, Granite Construction’s share price has eased back recently, but momentum over the longer term remains impressive. The stock’s 1-year total...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Alliance Resource Partners (ARLP): Exploring Valuation After Recent Modest Share Price Movements

Alliance Resource Partners (ARLP) shares have seen some modest movement lately, gaining just over 1% in the past week but dipping slightly over the past month. Investors might be eyeing recent performance for clues about where the stock could head next. See our latest analysis for Alliance Resource Partners. While Alliance Resource Partners’ recent share price has seen only minor shifts, its broader run tells a more compelling story. Despite a dip so far this year, its one-year total...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

A Look at Structure Therapeutics (GPCR) Valuation Following Q3 Losses and Investor Reaction

Structure Therapeutics (GPCR) released its third-quarter earnings on Wednesday, revealing a much wider net loss compared to the previous year. The financial update put the company’s recent performance under greater scrutiny for investors. See our latest analysis for Structure Therapeutics. Despite widening losses, Structure Therapeutics has caught investors’ attention, with the stock surging more than 105% over the past 90 days. This momentum far outpaces its 1-year total shareholder return...
NYSE:NABL
NYSE:NABLSoftware

N-able (NABL): Assessing Valuation After Q3 Beat, Raised Guidance, and New Cybersecurity Launches

N-able (NABL) shares are making headlines after the company released its third-quarter results, which beat expectations and sparked renewed interest. Investors are eyeing the raised annual recurring revenue outlook as well as the roll-out of fresh cybersecurity solutions. See our latest analysis for N-able. Following the upbeat earnings and guidance update, N-able’s share price charged 9.4% higher in the past week, recouping some ground after a tough year that saw its 12-month total...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Nova (NVMI) Is Down 8.7% After Record Q3 Results and Raised Guidance – Has the Bull Case Changed?

Nova Ltd. reported record third-quarter results with revenue of US$224.61 million and net income of US$61.42 million, alongside management issuing elevated fourth-quarter revenue guidance of US$215 million to US$225 million and diluted GAAP EPS of US$1.77 to US$1.95. The company highlighted exceptionally strong sales in advanced logic and memory segments, driving both its highest-ever quarterly sales and surpassing analysts’ expectations for the upcoming quarter. We'll explore how Nova's...
NasdaqGS:PCH
NasdaqGS:PCHSpecialized REITs

PotlatchDeltic (PCH): Is There More Value Ahead After Recent Share Price Rebound?

PotlatchDeltic (PCH) shares have edged up over the past day, reflecting a modest 2.5% gain. This follows a stretch where the stock has drifted slightly lower over the month; however, it remains positive year-to-date. See our latest analysis for PotlatchDeltic. PotlatchDeltic’s share price has perked up after some recent softness, but overall momentum has cooled. A 3.45% year-to-date share price return and a five-year total shareholder return of 27.2% highlight the company’s mixed journey...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC): Evaluating Valuation Following Earnings Beat, Revenue Surge, and Patent Resolution

BeOne Medicines (NasdaqGS:ONC) reported its third quarter earnings, surprising investors with a return to profitability and a sizable revenue jump. The results surpassed expectations and the company also provided an upward revision to full-year revenue guidance. See our latest analysis for BeOne Medicines. Momentum is clearly building behind BeOne Medicines. The 1-day share price return of 3.41%, a 7.83% gain over the last week, and an 80.63% share price return year-to-date all reflect...
NYSE:OXY
NYSE:OXYOil and Gas

Does the Recent Slide Make Occidental Petroleum a Hidden Opportunity for 2025?

Curious if Occidental Petroleum is actually a bargain right now? You are not alone, as plenty of investors are wondering if the current price reflects the true value of the business. After a 19.7% slide over the past year and down 19.1% so far this year, the stock's moves have turned heads, especially following a five-year gain of 276.1% that still looms large in investor memories. Recently, Occidental has drawn attention due to news surrounding its significant carbon capture investments and...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet (ZBH): Exploring Valuation After Recent Sector Pressure and Shifting Momentum

Zimmer Biomet Holdings (ZBH) stock has seen gradual shifts lately, prompting investors to review recent performance and underlying trends. The company’s share price has slid over the past month and past 3 months, reflecting broader pressures across the medical device sector. See our latest analysis for Zimmer Biomet Holdings. Zooming out, Zimmer Biomet Holdings’ momentum has clearly faded over the past year. Share price returns have slipped, and the total shareholder return was -18% for the...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

Why DENTSPLY SIRONA (XRAY) Is Down 12.5% After CFO Departure and Weak Q3 Results – And What's Next

On October 31, 2025, DENTSPLY SIRONA announced that Chief Financial Officer Matthew E. Garth would step down effective November 5, with CEO Daniel T. Scavilla assuming interim CFO duties while a search for a new executive begins. This leadership change was announced alongside third quarter results showing year-over-year declines in sales and ongoing net losses, highlighting continued operational and financial challenges for the company. We'll explore how the CFO transition amid ongoing...
NYSE:ARI
NYSE:ARIMortgage REITs

How Apollo’s Swing to Profitability in Q3 Changed Its Investment Story at Apollo Commercial Real Estate (ARI)

Apollo Commercial Real Estate Finance reported third-quarter 2025 earnings in the past week, achieving net income of US$50.79 million after a loss in the same quarter last year. This significant shift to profitability reflects improving fundamentals and was accompanied by more favorable assessments from multiple financial analysts. We’ll explore how Apollo’s return to profitability marks a potential turning point in its investment narrative after recent share price declines. AI is about to...
NYSE:UTZ
NYSE:UTZFood

Utz Brands (UTZ): Exploring the Value Opportunity After Recent Share Price Declines

Utz Brands (UTZ) stock has been on a rough streak lately, with shares falling 2% over the past week and down nearly 20% over the past month. The snack maker’s performance has caught the attention of investors, who are curious about the company’s next move amid ongoing volatility. See our latest analysis for Utz Brands. Utz Brands’ rough patch comes after a steady stretch of volatility, with the share price declining consistently over the past quarter and registering a year-to-date drop of...
NasdaqGS:DRVN
NasdaqGS:DRVNConsumer Services

Will Revenue Growth and Upbeat Guidance Reshape Driven Brands Holdings' (DRVN) Investment Narrative?

Driven Brands Holdings Inc. recently reported third quarter results, delivering year-over-year revenue growth to US$535.68 million, a turnaround to net income of US$60.86 million, and raised its full-year earnings guidance for 2025. The company's continued expansion of its Take 5 Oil Change segment, alongside organizational changes and improved leverage, signals a focus on strengthening both operational and financial stability. Let's examine how Driven Brands' improved profitability and...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian (RIVN): Evaluating Valuation After Strong Q3 Results and Raised Growth Expectations

Rivian Automotive (RIVN) shares climbed after the company delivered upbeat third-quarter results, beating both revenue and earnings estimates. Strong gross profit and a steady outlook for 2025 vehicle deliveries caught investors’ attention. See our latest analysis for Rivian Automotive. After a tough start to the year, Rivian Automotive has staged a sharp rebound in recent months. Stronger deliveries and new product launches have helped the company achieve a 29% share price return over the...
NYSE:BWA
NYSE:BWAAuto Components

BorgWarner (BWA): Assessing Valuation After Q3 Results and New Electrification Contract Wins

BorgWarner (NYSE:BWA) grabbed investor focus after releasing third quarter earnings and sharing its updated 2025 guidance. The company kept sales forecasts steady with market expectations. The news also highlighted several new wins in advanced electrification contracts. See our latest analysis for BorgWarner. BorgWarner’s momentum is picking up, with its latest contract wins and electrification progress fueling optimism. This is reflected by a year-to-date share price return of nearly 44% and...
NasdaqCM:POET
NasdaqCM:POETSemiconductor

Evaluating POET Technologies (NasdaqCM:POET): Is the Stock’s High Valuation Justified?

POET Technologies (NasdaqCM:POET) has drawn interest from investors recently as its stock price saw some shifts over the past month. With shares now trading at $5.32, there is curiosity about the catalysts influencing this movement. See our latest analysis for POET Technologies. While POET Technologies’ share price has been under pressure, sliding by 32.5% over the past month and 13.8% year-to-date, investors who held on over the longer term have seen impressive rewards, with a one-year total...
NasdaqGS:VLY
NasdaqGS:VLYBanks

Can Keating’s Appointment Reshape Valley National’s Lending Ambitions and Growth Narrative? (VLY)

Valley National Bancorp recently announced the appointment of Terry M. Keating as Head of Asset-Based Lending, following the retirement of John DePledge who established the bank’s ABL platform. Keating’s three-decade career in commercial finance and specialty lending signals Valley’s continued emphasis on expanding tailored financing solutions for middle-market clients. We will explore how Keating’s leadership and expertise in specialty lending may influence Valley National Bancorp’s growth...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

BioNTech (BNTX): Exploring Valuation Perspectives as Shares Drift Lower in 2024

BioNTech (BNTX) shares slipped slightly this week, closing at $103.35. The company is continuing to navigate a market recalibration following the pandemic-driven highs. Investors are keeping an eye on how revenue and income trends develop into the rest of the year. See our latest analysis for BioNTech. BioNTech’s share price has been gradually trending lower this year, with a 10.4% decline year-to-date reflecting cautious sentiment after last year’s pandemic surge faded. However, the one-year...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

Victoria's Secret (VSCO): Assessing Valuation After a 28% Share Price Surge

Victoria's Secret (VSCO) shares have seen significant swings over the past month, climbing nearly 28% even as retail stocks face mixed sentiment. Investors are weighing recent performance trends against the company's evolving positioning in the competitive apparel market. See our latest analysis for Victoria's Secret. The recent surge in Victoria's Secret's share price, especially the impressive 28% jump over the past month, stands out after a tough start to the year. While the 1-year total...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Assessing Braze (BRZE) Valuation as Investor Optimism Grows After Recent 90-Day Share Price Uptick

Braze (BRZE) stock has attracted interest as investors review its recent performance in the software sector. Shares have seen moderate movement over the past month, which gives traders reason to take a closer look at underlying results. See our latest analysis for Braze. Braze’s share price has had its ups and downs. While the stock is off 37% year-to-date, a recent 90-day share price return of 7.6% hints at some renewed investor optimism. Over the past year, however, total shareholder return...